Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 2, 1998, Pages 171-176

  Yoshida, Satoshi ^a   Amayasu, Hideaki ^a,b   Sakamoto, Hideo ^c   Onuma, Kazuya ^a   Shoji, Tatsuhiro ^a,d   Nakagawa, Hiroshi ^a   Tajima, Takayuki ^a  

^a AOKI International Medical Center   (Japan)

^b YOKOHAMA ROSAI HOSPITAL   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CROMOGLYCATE DISODIUM; DIPYRONE; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; PLACEBO;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME IMMUNOASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION;

EID: 0031952283     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62951-1     Document Type: Article

References (51)

1. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975;1:67-9.
2. Lee TH. Mechanism of aspirin sensitivity. Am Rev Respir Dis 1992; 145: 34-6.
3. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute National Asthma Education Program Expert Panel Report. J Allergy Clin Immunol 1991;88:425-534.
4. Schmutzler W, Bolsmann K, Zwadlo-Klarwasser G. Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells. Int Arch Allerg Immunol 1995;107:194-6.
5. Kay AB, Walsh GM, Moqbel R, et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Rheumatol 1987;14:299-301.
6. Rand TH, Lopez AF, Gamble JR, Vadas MA. Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxity. Int Arch Allergy Appl Immunol 1988;87: 151-4.
7. Diaz P, Galleguillos FR, Gonzalez MC, et al. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins and complement. J Allergy Clin Immunol 1984; 74:41-8.
8. 4 production by human B cells in vitro. Clin Exp Immunol 1991;84:395-9.
9. Obata T, Matsuda S, Akasawa A, Iikura Y. Preventive effect and duration of action of disodium cromoglycate and procaterol on exercise-induced asthma in asthmatic children. Ann Allergy 1993;70:123-6.
10. Dahl R. Oral and inhaled sodium cromoglycate in challenge test with food allergens or acetylsalicylic acid. Allergy 1981;36:161-5.
11. Mackay GA, Pearce FL. Extracellular guanosine 3′,5′-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils. Intern Arch Allergy Immunol 1996;109: 258-65.
12. Leonardi A, Borghesan F, Faggian D, et al. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995;50:610-3.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
14. Chai H, Farr RS, Froelich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
15. Makino S, Kobayashi S, Miyamoto T, et al. Standard for allergen bronchial provocation tests in asthma and hypersensitivity pneumonitis. Jap J Allerg 1982;31:1074-6.
16. Sestini P, Pieroni MG, Refini RM, et al. Time-limited protective effect of inhaled furosemide against aspirininduced bronchoconstriction in aspirin sensitive asthmatics. Eur Respir J 1994;7:1825-9.
17. 4. Prostaglandins 1994;47:281-92.
18. Houjou S, Dobashi K, Nakazawa T. Aspirin-induced asthma. Jap J Clin Med 1994;3:355-8.
19. Power I. Aspirin-induced asthma. Br J Anaest 1993;71:619-21.
20. Szczeklik A, Schmitz SM. Aspirininduced asthma: from pathogenesis to therapy. Allergy Immunopathol 1993; 21:35-40.
21. 4 during aspirin-induced asthma. J Lab Clin Med 1992;119:48-51.
22. Chung JTN, Jones RS. Bronchodilator effect of sodium cromoglycate and its clinical implications. Br Med J 1979; 2:1033-4.
23. Nasser SMS, Bell GS, Foster S, et al. Effect of the 5-lipoxygenase inhibitor ZD21138 on aspirin-induced asthma. Thorax 1994;49:749-54.
24. Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary LTE4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
25. Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirinsensitive asthmatics to aspirin. Am Rev Respir Dis 1993;148:1447-51.
26. Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993;6:391-9.
27. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994;149: 940-6.
28. Peter SP, Schulman ES, MacGlashan DW, et al. Pharmacological and biochemical studies of human lung mast cells. J Allergy Clin Immunol 1982;69: 150.
29. Booiji NH, Orie NGM, de Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and predonisolone. J Allergy 1971;48:344-8.
30. 4 levels during early and late asthmatic responses. J Allergy Clin Immunol 1990;86: 211-20.
31. Hui KP, Taylor JK, Taylor GW, et al. Effects of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991;46: 184-9.
32. Diaz P, Galleguillos FR, Gonzalez MC, et al. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol 1984; 74:41-8.
33. Gorski P, Palczynski C. Eosinophils in bronchial asthma. Allergy Immunopathol 1989;17:113-6.
34. Moqbel R, Walsh GM, Macdonald AJ, Kay B. Effect of disodium cromoglycate on activation of human eosinophils and neutrophils following reversed (anti-IgE) anaphylaxis. Clin Allergy 1986;16:73-83.
35. Correia I, Wang L, Pang X, Theoharides TC. Characterization of the 78 kDa mast cell protein phosphorylated by the antiallergic drug cromolyn and homology to moesin. Biochem Pharmacol 1996;52:413-24.
36. Hoshino M, Nakamura Y. The effect of disodium cromoglycate (DSCG) on infiltration of inflammatory cells into bronchial mucosa and on expression of adhesion molecules in asthmatics. Jap J Allergol 1995;44:593-601.
37. Kay AB, Walsh GM, Moqbel R, et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 1987; 80:1-8.
38. Crimi N, Palermo F, Oliveri R, et al. Bronchospasm induced by inhalation of substance P: effect of sodium cromoglycate. Respiration 1988;54:95-9.
39. Page C. Sodium cromoglycate, a tachykinin antagonist? Lancet 1994; 343:70.
40. Yamawaki I, Tamaoki J, Takeda Y, Konnno K. Effect of sodium cromoglycate on airway vascular leakage caused by hypertonic saline in the rat trachea. Jap J Thorac Dis 1996;34:973-7.
41. Crossman DC, Dashwood MR, Taylor GW, et al. Sodium cromoglycate: evidence of tachykinin antagonist activity in the human skin. J Appl Physiol 1993;75:167-72.
42. Sagara H, Yukawa T, Arima M, Makino S. Effect of capsaicin on the migration of eosinophils into the bronchi of guinea pigs. Jap J Allergol 1993; 42:236-42.
43. Noveral JP, Grunstein MM. Tachykinin regulation of airway smooth muscle cell proliferation. Am J Physiol 1995;269:339-43.
44. Murris EM, Pinelli E, Pipy B, Leophonte P, Didier A. Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production. Allergy 1995;50:334-9.
45. Ichinose M, Miura M, Takahashi T, et al. Neurogenic inflammation. Jap J Thorac Dis 1993;31:172-5.
46. Verleden GM. Neural mechanisms and axon reflexes in asthma. Where are we? Biochem Pharmacol 1996;51: 1247-57.
47. 2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153: 572-5.
48. Brunelleschi S, Parenti A, Ceni E, et al. Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. Br J Pharmacol 1992;107:964-9.
49. 2 alpha-induced contraction of isolated guinea pig bronchi is mediated in part by release of tachykinins. J Appl Physiol 1995; 79:1411-8.
50. Martin JG. Animal models of bronchial hyperactivity. Rev Malad Respir 1994;11:93-9.
51. Stevenson DD, Pleskow WW, Simon RA, et al. Cromolyn pre-treatment delays onset of ASA induced reactions. J Allergy Clin Immunol 1984;73:162.